These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8061799)
1. Interferon retreatment of nonresponders with HCV-RNA-positive chronic hepatitis C. Arase Y; Kumada H; Chayama K; Tsubota A; Koida I; Ikeda K; Saitoh S; Matsumoto T; Kobayashi M J Gastroenterol; 1994 Jun; 29(3):299-304. PubMed ID: 8061799 [TBL] [Abstract][Full Text] [Related]
2. Retreatment of chronic hepatitis C with interferon. Toyoda H; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Suga T; Ohki H; Ito O Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572 [TBL] [Abstract][Full Text] [Related]
3. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C. Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941 [TBL] [Abstract][Full Text] [Related]
4. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C. Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750 [TBL] [Abstract][Full Text] [Related]
5. alpha-Interferon retreatment of patients with chronic hepatitis C. Rabinovitz M; Block G; Finkelstein SD Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654 [TBL] [Abstract][Full Text] [Related]
6. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment. Weiland O; Zhang YY; Widell A Scand J Infect Dis; 1993; 25(1):25-30. PubMed ID: 8384732 [TBL] [Abstract][Full Text] [Related]
7. Changes of serum hepatitis C virus levels in patients with chronic hepatitis C treated with two courses of interferon administration. Saitoh Y; Miura M; Niitsuma H; Numata N; Ohori H; Ishii M; Toyota T Tohoku J Exp Med; 1994 Aug; 173(4):361-9. PubMed ID: 7529950 [TBL] [Abstract][Full Text] [Related]
8. Short and long-term effects of interferon on serum markers of hepatitis C virus replication. Yatsuhashi H; Inoue O; Inokuchi K; Koga M; Nagataki S; Cha TA; Irvine B; Stempien M; Kolberg J; Urdea MS J Gastroenterol Hepatol; 1993; 8(1):1-6. PubMed ID: 8382537 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers. Okazaki T; Yoshihara H; Suzuki K; Yamada Y; Tsujimura T; Kawano K; Yamada Y; Abe H Scand J Gastroenterol; 1994 Nov; 29(11):1039-43. PubMed ID: 7871371 [TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders. Hakozaki Y; Shirahama T; Katou M; Nakagawa K; Oba K; Yoshii O; Matsumoto T; Kuwabara N; Mitamura K Am J Gastroenterol; 1996 Oct; 91(10):2144-9. PubMed ID: 8855738 [TBL] [Abstract][Full Text] [Related]
12. Serial density analysis of hepatitis C virus particle populations in chronic hepatitis C patients treated with interferon-alpha. Kanto T; Hayashi N; Takehara T; Hagiwara H; Mita E; Oshita M; Katayama K; Kasahara A; Fusamoto H; Kamada T J Med Virol; 1995 Jul; 46(3):230-7. PubMed ID: 7561795 [TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment. Orito E; Mizokami M; Suzuki K; Ohba KI; Ohno T; Mizuno M; Iijima Y; Saito H; Nemoto A; Nukuta N J Gastroenterol Hepatol; 1997 Jan; 12(1):58-61. PubMed ID: 9076625 [TBL] [Abstract][Full Text] [Related]
15. Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion. Hosoda K; Yokosuka O; Kato N; Ito Y; Ohto M; Omata M Gastroenterol Jpn; 1993 May; 28 Suppl 5():115-7. PubMed ID: 8395437 [TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group. Heathcote EJ; James S; Mullen KD; Hauser SC; Rosenblate H; Albert DG Hepatology; 1999 Aug; 30(2):562-6. PubMed ID: 10421669 [TBL] [Abstract][Full Text] [Related]
17. Dose increase augments response rate to interferon-alpha in chronic hepatitis C. Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466 [TBL] [Abstract][Full Text] [Related]
18. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C. Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523 [TBL] [Abstract][Full Text] [Related]
19. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Muratori L; Giostra F; Cataleta M; Francesconi R; Ballardini G; Cassani F; Lenzi M; Bianchi FB Liver; 1994 Jun; 14(3):124-8. PubMed ID: 8078391 [TBL] [Abstract][Full Text] [Related]
20. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. Kobayashi Y; Watanabe S; Konishi M; Yokoi M; Kakehashi R; Kaito M; Kondo M; Hayashi Y; Jomori T; Suzuki S Hepatology; 1993 Dec; 18(6):1319-25. PubMed ID: 8244255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]